Published online Oct 27, 2026. doi: 10.4254/wjh.125241
Revised: August 3, 2026
Accepted: September 15, 2026
Published online: October 27, 2026
Processing time: 106 Days and 18.1 Hours
Acute hemobilia is an uncommon complication of computed tomography (CT)-guided percutaneous liver biopsy.
We report a 57-year-old man with colorectal liver metastases. He underwent biopsy due to disease progression after multiple lines of anticancer therapy, including antiangiogenic agents and chimeric antigen receptor T-cell therapy. During stepwise withdrawal of the coaxial cannula, he suddenly developed severe right upper quadrant pain, diaphoresis, nausea, sinus tachycardia, and a positive Murphy’s sign. Immediate non-contrast CT revealed marked gallbladder distention and new hyperattenuating contents compared with preprocedural imaging. Acute hemobilia was diagnosed based on the timing of symptom onset, clinical findings, and CT features. His symptoms resolved with conservative management. Previous therapies may have contributed to the endothelial injury and microvascular fragility, while loss of the tamponade effect during cannula withdrawal may have allowed bleeding into an injured biliary structure.
Prophylactic gelatin sponge tract embolization warrants consideration when suspected microvascular fragility coexists with technically complex biopsy.
Core Tip: We report a case of a heavily pretreated patient who developed acute hemobilia during coaxial cannula withdrawal after computed tomography-guided liver biopsy. Immediate non-contrast computed tomography and physical signs enabled prompt diagnosis. Loss of mechanical tamponade and possible treatment-related vascular vulnerability were considered plausible, although they are unconfirmed contributing factors. In selected cases, prophylactic gelatin sponge tract embolization during coaxial cannula withdrawal may be considered a reasonable preventive option.